stoxline Quote Chart Rank Option Currency Glossary
  
Aurora Cannabis Inc. (ACB)
3.43  -0.05 (-1.44%)    04-10 16:00
Open: 3.48
High: 3.54
Volume: 328,625
  
Pre. Close: 3.48
Low: 3.405
Market Cap: 195(M)
Technical analysis
2026-04-10 4:34:31 PM
Short term     
Mid term     
Targets 6-month :  4.27 1-year :  4.99
Resists First :  3.66 Second :  4.27
Pivot price 3.34
Supports First :  3.29 Second :  3.06
MAs MA(5) :  3.43 MA(20) :  3.36
MA(100) :  4.02 MA(250) :  4.58
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  74.5 D(3) :  71.2
RSI RSI(14): 49.1
52-week High :  6.66 Low :  3.06
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ ACB ] has closed below upper band by 29.0%. Bollinger Bands are 49.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 3.54 - 3.56 3.56 - 3.58
Low: 3.36 - 3.38 3.38 - 3.4
Close: 3.4 - 3.43 3.43 - 3.47
Company Description

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Headline News

Sat, 11 Apr 2026
Aurora Cannabis Inc. Trade Ideas — BSESOF:21P - TradingView — Track All Markets

Sat, 11 Apr 2026
Aurora Cannabis Inc. Trade Ideas — BSESOF:21P - TradingView — Track All Markets

Mon, 30 Mar 2026
Aurora Cannabis (NASDAQ: ACB) earns Women Lead Here recognition again - Stock Titan

Tue, 03 Mar 2026
Canaccord Initiates Aurora Cannabis Inc. (ACB) With C$10 Price Target - Yahoo Finance

Sun, 15 Feb 2026
Canaccord is Bullish on Aurora Cannabis Inc. (ACB) - Yahoo Finance

Wed, 04 Feb 2026
Aurora Cannabis (NASDAQ: ACB) launches U.S.$100M at-the-market share program - Stock Titan

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Shares Out 57 (M)
Shares Float 56 (M)
Held by Insiders 0 (%)
Held by Institutions 12.9 (%)
Shares Short 7,300 (K)
Shares Short P.Month 8,200 (K)
Stock Financials
EPS -1.09
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 6.82
Profit Margin -22.6 %
Operating Margin 2.3 %
Return on Assets (ttm) -4.4 %
Return on Equity (ttm) -15.6 %
Qtrly Rev. Growth 6.8 %
Gross Profit (p.s.) 2.37
Sales Per Share 6.57
EBITDA (p.s.) -0.58
Qtrly Earnings Growth -94.7 %
Operating Cash Flow -10 (M)
Levered Free Cash Flow 12 (M)
Stock Valuations
PE Ratio -3.18
PEG Ratio 0
Price to Book value 0.5
Price to Sales 0.52
Price to Cash Flow -20.27
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android